Exclusive: Pfizer chiefs sold £15m of their own shares weeks before bid

Top level management sales emerge as big US investors sell down their stakes

Deputy Business editor

Pfizer's chief executive and top scientist, who have been doing the rounds of MPs, research heads and City investors this week promoting their proposed £63bn takeover bid for AstraZeneca, sold more than $12m (£7m) of their own shares in the US giant just two months ago.

Analysts said the sales – coming from such senior employees as Ian Read and Mikael Dolsten – were hardly likely to engender confidence in the company among AstraZeneca shareholders. A large majority of the payment for the UK company is proposed to be made up of Pfizer shares.

The sales followed only a little over six weeks after Pfizer's first bid approach to AstraZeneca and less than two months before the American company came back with an official announcement of a possible offer.

Pfizer's CEO and chairman Ian Read sold $10.6m of his shares on 26 February and subsequently exercised share options worth a further $4.1m. Mikael Dolsten's share sales, totalling about $2m were made on 26 February and 4 March, regulatory filings show. Both men's trades were made before the slump in Pfizer's share price that followed news of its takeover interest.

At today's Pfizer share price, Mr Read's share sale would have fetched $956,000 less, and Mr Dolsten's would been down by $225,000. Both directors remain huge shareholders in the company despite their recent disposals.

Pfizer's Mr Read first sounded out AstraZeneca over a possible takeover in January but was rebuffed. It is not known if Mr Dolsten was aware of that takeover approach, although his status as a key architect of the current deal is clear given that he was chosen to address the Science Select Committee of MPs this week. Mr Dolsten was also chosen to promote the takeover alongside Mr Read in videos earlier this week.

Share prices of the bidding company generally fall before a takeover due to the inherent risk involved in such transactions.

Mr Dolsten and Mr Read were far from being the only top employees selling shares shortly before January's takeover approach was reheated. Frank Damelio, the chief financial officer, sold nearly $9m and exercised $4m of shares.

Loretta Cangialosi, senior vice president and controller sold more than $3m-worth, while Sally Susman, executive vice president of policy, external affairs and communications, sold more than $2.2m-worth.

There is no suggestion of wrongdoing on the part of any of the individuals. When asked about the share sales, Pfizer said directors are only allowed to sell or buy shares at certain times of the year. "These sales were within guidelines and during a permissible period. The executives remain in compliance with their stock ownership requirements," it added.

Details of the share sales came as the Science Select Committee of MPs declared the potential takeover posed a threat to British science unless Pfizer could give more concrete, enforceable guarantees on jobs and investment.

Andrew Miller, who is the chairman of the Science Select Committee, which questioned executives from both firms on Wednesday, said he was not satisfied with Pfizer's promises or convinced of the Government's ability to enforce them.

"The national stake in the proposed transaction with Pfizer is unusually high: any threat to AstraZeneca's research capacity must, to an extent, be considered a threat to UK science," Mr Miller said in a letter to the Science minister David Willetts.

"Whether or not the government is able to hold Pfizer to these promises – and we are not yet confident it can – further, longer-term guarantees need to be obtained before we can be confident of Pfizer's commitment to the UK."

Mr Miller said that five-year commitments were of limited value in an industry that "measures progress by decades rather than years".

Shareholders have received the US company's approaches more warmly, however, and many still say an increased takeover offer, from the latest $50-a-share to more than $55 should be enough to prompt AstraZeneca to open discussions.

However, pressure is clearly mounting on Mr Read over the deal back home in the US, where Pfizer's major shareholders have sold hundreds of millions of dollars of its stock this week.

Bank of New York Mellon alone has sold $392m and FMR has ditched $435m of Pfizer shares according to Bloomberg's share register.

Start your day with The Independent, sign up for daily news emails
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Claims Administrator

£16000 - £18500 per annum: Recruitment Genius: This is an excellent opportunit...

Recruitment Genius: Senior SEO Executive

£24000 - £28000 per annum: Recruitment Genius: A Senior SEO Executive is requi...

Recruitment Genius: Online Customer Service Administrator

£16000 - £18000 per annum: Recruitment Genius: An Online customer Service Admi...

Recruitment Genius: Digital Marketing Executive

£18000 - £22000 per annum: Recruitment Genius: This global, industry leading, ...

Day In a Page

'It was first time I had ever tasted chocolate. I kept a piece, and when Amsterdam was liberated, I gave it to the first Allied soldier I saw'

Bread from heaven

Dutch survivors thank RAF for World War II drop that saved millions
Britain will be 'run for the wealthy and powerful' if Tories retain power - Labour

How 'the Axe' helped Labour

UK will be 'run for the wealthy and powerful' if Tories retain power
Rare and exclusive video shows the horrific price paid by activists for challenging the rule of jihadist extremists in Syria

The price to be paid for challenging the rule of extremists

A revolution now 'consuming its own children'
Welcome to the world of Megagames

Welcome to the world of Megagames

300 players take part in Watch the Skies! board game in London
'Nymphomaniac' actress reveals what it was really like to star in one of the most explicit films ever

Charlotte Gainsbourg on 'Nymphomaniac'

Starring in one of the most explicit films ever
Robert Fisk in Abu Dhabi: The Emirates' out-of-sight migrant workers helping to build the dream projects of its rulers

Robert Fisk in Abu Dhabi

The Emirates' out-of-sight migrant workers helping to build the dream projects of its rulers
Vince Cable interview: Charging fees for employment tribunals was 'a very bad move'

Vince Cable exclusive interview

Charging fees for employment tribunals was 'a very bad move'
Iwan Rheon interview: Game of Thrones star returns to his Welsh roots to record debut album

Iwan Rheon is returning to his Welsh roots

Rheon is best known for his role as the Bastard of Bolton. It's gruelling playing a sadistic torturer, he tells Craig McLean, but it hasn't stopped him recording an album of Welsh psychedelia
Russell Brand's interview with Ed Miliband has got everyone talking about The Trews

Everyone is talking about The Trews

Russell Brand's 'true news' videos attract millions of viewers. But today's 'Milibrand' interview introduced his resolutely amateurish style to a whole new crowd
Morne Hardenberg interview: Cameraman for BBC's upcoming show Shark on filming the ocean's most dangerous predator

It's time for my close-up

Meet the man who films great whites for a living
Increasing numbers of homeless people in America keep their mobile phones on the streets

Homeless people keep mobile phones

A homeless person with a smartphone is a common sight in the US. And that's creating a network where the 'hobo' community can share information - and fight stigma - like never before
'Queer saint' Peter Watson left his mark on British culture by bankrolling artworld giants

'Queer saint' who bankrolled artworld giants

British culture owes a huge debt to Peter Watson, says Michael Prodger
Pushkin Prizes: Unusual exchange programme aims to bring countries together through culture

Pushkin Prizes brings countries together

Ten Scottish schoolchildren and their Russian peers attended a creative writing workshop in the Highlands this week
14 best kids' hoodies

14 best kids' hoodies

Don't get caught out by that wind on the beach. Zip them up in a lightweight top to see them through summer to autumn
Robert Fisk in Abu Dhabi: The acceptable face of the Emirates

The acceptable face of the Emirates

Has Abu Dhabi found a way to blend petrodollars with principles, asks Robert Fisk